We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+10.68%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.73B
AUM Growth
-$32.7M
Cap. Flow
-$304M
Cap. Flow %
-5.3%
Top 10 Hldgs %
52.96%
Holding
258
New
61
Increased
37
Reduced
51
Closed
64

Top Buys

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$103M
2
AMZN icon
Amazon
AMZN
+$91.5M
3
BIIB icon
Biogen
BIIB
+$49.7M
4
PARA
Paramount Global Class B
PARA
+$49.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$48.3M

Top Sells

Rank Stock Value
1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$101M
2
ROST icon
Ross Stores
ROST
+$100M
3
FIVE icon
Five Below
FIVE
+$76.2M
4
LULU icon
lululemon athletica
LULU
+$76.1M
5
INCY icon
Incyte
INCY
+$73M

Sector Composition

Rank Sector Weight
1 Healthcare 45.98%
2 Consumer Staples 5.76%
3 Technology 4.46%
4 Consumer Discretionary 4.37%
5 Communication Services 3.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPNE
101
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$4.48M 0.08%
+536,000
New +$3.61M
ADV icon
102
Advantage Solutions
ADV
$439M
$4.39M 0.08%
84,440
-11,560
-12% -$726K
SGFY
103
DELISTED
Signify Health, Inc.
SGFY
$4.3M 0.08%
+150,000
New +$4.33M
CMG icon
104
Chipotle Mexican Grill
CMG
$43.7B
$4.16M 0.07%
+150,000
New +$4.48M
ONEM
105
DELISTED
1Life Healthcare
ONEM
$4.14M 0.07%
+248,000
New +$4.19M
OPTN
106
DELISTED
OptiNose
OPTN
$3.69M 0.06%
+133,099
New +$5.05M
CANO
107
DELISTED
Cano Health, Inc.
CANO
$3.66M 0.06%
+26,720
New +$9.05M
CKPT
108
DELISTED
Checkpoint Therapeutics
CKPT
$3.54M 0.06%
+691,895
New +$4.98M
ACXP icon
109
Acurx Pharmaceuticals
ACXP
$6.32M
$3.5M 0.06%
44,000
-9,300
-17% -$612K
ABEO icon
110
Abeona Therapeutics
ABEO
$388M
$3.41M 0.06%
+1,106,000
New +$4.14M
GTBP icon
111
GT Biopharma
GTBP
$11.4M
$3M 0.05%
+113,000
New +$5.64M
ARDS
112
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
$2.44M 0.04%
+2,068,000
New +$2M
OTLY
113
Oatly Group
OTLY
$445M
$2.35M 0.04%
+67,500
New +$2.58M
GTEC icon
114
Greenland Technologies Holding
GTEC
$14.3M
$2.33M 0.04%
1,070,974
-106,026
-9% -$230K
PTN
115
Palatin Technologies
PTN
$14.1M
$2.17M 0.04%
+16,930
New +$3.64M
IMV
116
DELISTED
IMV Inc. Common Shares
IMV
$2.13M 0.04%
+875,000
New +$2.81M
MBOT icon
117
Microbot Medical
MBOT
$124M
$2.08M 0.04%
+690,000
New +$2.86M
NOMD icon
118
Nomad Foods
NOMD
$1.65B
$1.72M 0.03%
+100,000
New +$1.58M
ALPP
119
DELISTED
Alpine 4 Holdings Inc
ALPP
$1.7M 0.03%
402,023
-610,477
-60% -$3.01M
AKTX
120
Akari Therapeutics
AKTX
$13.1M
$1.63M 0.03%
4,338
-1,025
-19% -$424K
MGAM
121
DELISTED
Mobile Global Esports Inc. Common Stock
MGAM
$1.56M 0.03%
1,886,793
– –
SRGA
122
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$1.55M 0.03%
+781,000
New +$1.93M
CYTH
123
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
$1.32M 0.02%
+930,000
New +$1.54M
PBYI icon
124
Puma Biotechnology
PBYI
$407M
$1.27M 0.02%
300,000
-700,000
-70% -$2.42M
RMTI icon
125
Rockwell Medical
RMTI
$28.7M
$1.23M 0.02%
121,008
+25,108
+26% +$269K
3 4
5
6 7

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Armistice Capital held 258 positions worth $5.73B, down 0.57% from $5.76B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Armistice Capital withdrew a net $304M in Q4 2022, closing 64 positions and reducing 51 holdings. Its most notable exit was Five Below, an estimated $76.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 43% a quarter earlier, followed by Consumer Staples and Technology.

Against the trend, Armistice Capital opened a new position in CVS Health worth $44.4M.

  • Armistice Capital's largest Q4 2022 buy was CVS Health: 476,000 shares worth $44.4M.
  • Armistice Capital added most to Mirati Therapeutics, Inc. Common Stock in Q4 2022, an estimated $103M increase.
  • Armistice Capital's biggest Q4 2022 reduction was Madrigal Pharmaceuticals, cutting an estimated $101M.
  • Armistice Capital fully exited Five Below in Q4 2022, selling an estimated $76.2M.
  • Armistice Capital's ten largest holdings make up 53% of its $5.73B portfolio in Q4 2022.
  • Armistice Capital opened 61 new positions and closed 64 in Q4 2022.
  • Armistice Capital's portfolio value fell 0.57% quarter-over-quarter to $5.73B.

Based on Armistice Capital's 13F filing for Q4 2022, filed 14 Feb 2023.